Clinical Study of Cardiomyopeptidin on Postoperative Ischemia-reperfusion Injury in Patients With Primary PCI

NCT03958422 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Survival Myocardial Area After Acute Myocardial Death
Left Ventricular Ejection Fraction

Interventions

DRUG: cardiomyopeptidin

Sponsor

Dalian Zhen-Ao Bio-Tech Co., Ltd.